Original Literature | Model OverView |
---|---|
Publication
Title
Role of phosphoinositide 3-kinase in innate immunity.
Affiliation
Division of Molecular Medical Science, Graduate School of Biomedical Sciences,Hiroshima University, Hiroshima, Japan. khazeki@hiroshima-u.ac.jp
Abstract
Recent advances in our understanding of the molecular basis of mammalian hostimmune responses to microbial invasion suggest that the first line of defenseagainst microbes is the recognition of pathogen-associated molecular patterns byToll-like receptors (TLRs). Phosphoinositide 3-kinase (PI3K) is thought toparticipate in the TLR signaling pathway. The activation of PI3K is commonlyobserved after stimulation with various TLR ligands. The resultant activation ofa serine-threonine protein kinase Akt leads to the phosphorylation of glycogensynthase kinase (GSK)-3beta, which is active in resting cells but is inactivatedby phosphorylation. GSK-3beta has been linked to the regulation of a multitudeof transcription factors, including NF-kappaB, AP-1, NF-AT, and CREB eithernegatively or positively. Thus, the altered activity of GSK-3beta causes diverseeffects on cytokine expression. Generally, activation of PI3K results in theinhibition of proinflammatory events such as expression of IL-12 and TNF-alpha.Thus, PI3K is a negative regulator of TLR signaling. Among the members of theClass I PI3K family, p85/p110beta appears to be the subtype activated on TLRligation, but the molecular basis for this specificity has yet to be elucidated.
PMID
17827709
|
Entity
Process
IFN-gamma
--
G010453
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93423
10
infinite
0
TRANSFAC | G010453 |
--
PI3K
--
MO000000030
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m27
10
infinite
0
TRANSPATH | MO000000030 |
--
AKT
--
MO000000048
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m78
10
infinite
0
TRANSPATH | MO000000048 |
--
NF-kappaB{active}
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18
10
infinite
0
TRANSPATH | MO000000058 |
--
RIP1
--
MO000000065
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m97
10
infinite
0
InterPro | IPR000198 |
TRANSPATH | MO000000065 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
IRAK
--
MO000000213
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m184
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000213 |
--
TNF-alpha
--
MO000000289
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m230
10
infinite
0
InterPro | IPR003636 |
TRANSPATH | MO000000289 |
--
IRF-3
--
MO000007694
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m977
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007694 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
IL-1beta
--
MO000016597
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1591
10
infinite
0
TRANSPATH | MO000016597 |
--
IKK-i
--
MO000016608
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1599
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
IFNgamma
--
MO000016665
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1639
10
infinite
0
InterPro | IPR002069 |
TRANSPATH | MO000016665 |
--
GSK3
--
MO000016941
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1853
10
infinite
0
TRANSPATH | MO000016941 |
--
p110alpha
--
MO000017257
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m2113
10
infinite
0
InterPro | IPR002420 |
TRANSPATH | MO000017257 |
--
IL-12
--
MO000017265
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m2121
10
infinite
0
TRANSPATH | MO000017265 |
--
TBK1
--
MO000019331
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3902
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
IRAK-4
--
MO000039077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17258
10
infinite
0
TRANSPATH | MO000039077 |
--
TRIF
--
MO000041125
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m18998
10
infinite
0
TRANSPATH | MO000041125 |
--
dsRNA:TLR3:TRIF
--
MO000041437
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19305
10
infinite
0
TRANSPATH | MO000041437 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
IFN inducible genes
--
e100
cso30:c:mRNA
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m109
0
infinite
0
--
dsRNA:TLR3:TRIF:TBK1:IKK-i:RIP1
--
e101
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m110
0
infinite
0
--
NO
--
e11
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m11
0
infinite
0
--
Cyclooxygenase
--
e12
cso30:c:mRNA
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m12
0
infinite
0
--
LY294002
--
e13
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m13
0
infinite
0
--
TLR5:Flagellin
--
e14
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m14
0
infinite
0
--
IL-8
--
e15
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m15
0
infinite
0
--
CREB:CBP
--
e16
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m16
0
infinite
0
--
p65:CBP
--
e18
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m19
0
infinite
0
--
--
e19
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
--
e20
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m21
0
infinite
0
--
--
e21
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m22
0
infinite
0
--
LPS:TLR4:MyD88
--
e22
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m23
0
infinite
0
--
LPS:TLR4:TIRAP
--
e23
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m24
0
infinite
0
--
LPS:TLR4:TRAM
--
e24
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m25
0
infinite
0
--
TLR2:PGN
--
e25
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m26
0
infinite
0
--
TLR2:PGN:MyD88
--
e26
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
TLR2:PGN:MyD88:TIRAP
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m29
0
infinite
0
--
TLR7:ssRNA
--
e28
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m30
0
infinite
0
--
TLR9:CpGDNA
--
e29
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m31
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
LPS:TLR4:MyD88:IRAK-4
--
e30
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m32
0
infinite
0
--
LPS:TLR4:MyD88:IRAK-4:IRAK1
--
e31
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m33
0
infinite
0
--
TLR2:PGN:MyD88:IRAK-4
--
e32
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m34
0
infinite
0
--
TLR2:PGN:MyD88:IRAK-4:IRAK1
--
e33
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m35
0
infinite
0
--
TLR2:PGN:MyD88:IRAK-4:IRAK1:TRAF6
--
e34
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m36
0
infinite
0
--
LPS:TLR4:MyD88:IRAK-4:IRAK1:TRAF6
--
e35
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m37
0
infinite
0
--
TAK1{active}
--
e36
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m38
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016574 |
--
ssRNA
--
e37
cso30:c:Rna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m39
0
infinite
0
--
TLR9:CpGDNA:MyD88
--
e38
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m40
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRAk-4
--
e39
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
TLR7:ssRNA:MyD88
--
e40
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m42
0
infinite
0
--
TLR7:ssRNA:MyD88:IRAK4
--
e41
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m43
0
infinite
0
--
TLR7:ssRNA:MyD88:IRAK4:IRAK1
--
e42
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m44
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRAk-4:IRAK1
--
e43
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m45
0
infinite
0
--
TLR7:ssRNA:MyD88:IRAK4:IRAK1:TRAF6
--
e44
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m46
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRAk-4:IRAK1:TRAF6
--
e45
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m47
0
infinite
0
--
IKappaB:NF-KappaB
--
e47
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m49
0
infinite
0
--
IKappaB{p}:NF-KappaB
--
e48
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m63
0
infinite
0
--
IKappaB{p}{ub}:NF-KappaB
--
e49
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m64
0
infinite
0
--
wortmannin
--
e5
cso30:c:SmallMolecule
cso30:i:CC_Cytosol
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
LPS:TLR4
--
e6
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
degradants
--
e63
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m65
0
infinite
0
--
Inflammatory cytokines
--
e65
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m67
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
CAMP dependent kinase
--
e72
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m79
0
infinite
0
--
TNF-alpha
--
e74
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m81
0
infinite
0
--
IL-12
--
e75
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m82
0
infinite
0
--
Inhibitors of PI3K
--
e78
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m85
0
infinite
0
--
p85
--
e79
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m86
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
PI3K{active}
--
e80
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m87
10
infinite
0
TRANSPATH | MO000000030 |
--
LPS:TLR4:MyD88:p85
--
e81
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m88
0
infinite
0
--
TLR5:Flagellin:MyD88
--
e82
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m89
0
infinite
0
--
TLR5:Flagellin:MyD88:p85
--
e83
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m90
0
infinite
0
--
p85 receptor
--
e84
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m91
0
infinite
0
--
p85:p85 receptor
--
e85
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m93
0
infinite
0
--
TLR2:PGN:p85
--
e86
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m94
0
infinite
0
--
TLR3:dsRNA:TRIF:p85
--
e87
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m95
0
infinite
0
--
TRIF:p110alpha
--
e88
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m96
0
infinite
0
--
RIP1:p85
--
e89
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m98
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
AKT{active}
--
e90
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m99
10
infinite
0
TRANSPATH | MO000000048 |
--
CpGDNA
--
e91
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m100
0
infinite
0
--
TNF-alpha receptor
--
e92
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m101
0
infinite
0
--
TNF-alpha:TNF-alpha receptor
--
e93
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m102
0
infinite
0
--
Src-family tyrosine kinase
--
e94
cso30:c:Protein
cso30:i:CC_Cytoplasm
--
--
csml-variable:Double
m103
0
infinite
0
--
Src family tyrosine kinase:TRAF6
--
e95
cso30:c:Complex
cso30:i:CC_Cytoplasm
--
csml-variable:Double
m104
0
infinite
0
--
LPS:TLR4:TRAM:TRIF
--
e96
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m105
0
infinite
0
--
LPS:TLR4:TRAM:TRIF:TBK1:IKK-i:Rip1
--
e97
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m106
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 17827709,9398628 Prior to the discovery of TLR, wortmannin was reported to enhance LPS-induced NO production in macrophages
p9
p10
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c31 : 1
stoichiometry:c33 : 1
stoichiometry:c34 : 1
stoichiometry:c32 : 1
m93248*m14*m5*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
p100
p100
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c303 : 1
stoichiometry:c305 : 1
stoichiometry:c306 : 1
stoichiometry:c304 : 1
m78*m6*m97*0.1
nodelay
--
0
PMID: 17827709,15280422 RIP1 is another candidate for the adaptor of p85 in TLR signaling, since neither LPS nor CpG activates Akt in cells lacking RIP1.
p100
p101
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c307 : 1
stoichiometry:c309 : 1
stoichiometry:c310 : 1
stoichiometry:c308 : 1
m78*m97*m31*0.1
nodelay
--
0
PMID: 17827709,15280422 RIP1 is another candidate for the adaptor of p85 in TLR signaling, since neither LPS nor CpG activates Akt in cells lacking RIP1.
p102
p102
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c311 : 1
stoichiometry:c312 : 1
stoichiometry:c313 : 1
m230*m101*0.1
nodelay
--
0
--
p103
p103
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c314 : 1
stoichiometry:c315 : 1
stoichiometry:c316 : 1
stoichiometry:c317 : 1
m103*m183*m102*0.1
nodelay
--
0
PMID: 17827709,10635328 Stimulation of TNF receptors induces the binding of TRAF6 to Src-family tyrosine kinases to activate PI3K.
p104
p104
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c318 : 1
stoichiometry:c319 : 1
stoichiometry:c320 : 1
m104*m27*0.1
nodelay
--
0
PMID: 17827709,10635328 Stimulation of TNF receptors induces the binding of TRAF6 to Src-family tyrosine kinases to activate PI3K.
p105
p105
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c322 : 1
stoichiometry:c323 : 1
stoichiometry:c324 : 1
stoichiometry:c325 : 1
stoichiometry:c327 : 1
stoichiometry:c326 : 1
m3902*m183*m97*m1599*m6*0.1
nodelay
--
0
PMID: 17827709 This pathway requires a TIR domain-containing adaptor TICAM1/TRIF that interacts with TBK1, IKKi, RIP1, and TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c355 : 1
stoichiometry:c358 : 1
stoichiometry:c360 : 1
m6*m5*0.1
nodelay
--
0
PMID: 17827709,9794431 The activation of a receptor tyrosine kinase, RON, inhibits the LPS-induced expression of iNOS in murine peritoneal macrophages; this inhibition is recovered by wortmannin administration. PMID: 17827709,10868937 In b -pancreatic cells, LPS induces the expression of iNOS, which is abrogated by insulinlike growth factor-1 (IGF-1) PMID: 17827709 The effect of IGF-1 is inhibited by wortmannin, LY294002, and the overexpression of Dp85.
p107
p107
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c328 : 1
stoichiometry:c330 : 1
stoichiometry:c329 : 1
m977*m106*0.1
nodelay
--
0
PMID: 17827709 The nuclear translocation of IRF3 is triggered by phosphorylation with TBK1 and IKKi.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c331 : 1
stoichiometry:c332 : 1
m107*0.1
nodelay
--
0
PMID: 17827709 The nuclear translocation of IRF3 is triggered by phosphorylation with TBK1 and IKKi.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c333 : 1
stoichiometry:c334 : 1
m108*0.1
nodelay
--
0
PMID: 17827709 Treatment of macrophages and dendritic cells (DCs) with dsRNA or LPS results in IRF3 activation, which leads to the expression of IFN-b and the IFN-inducible gene products.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
stoichiometry:c38 : 1
stoichiometry:c37 : 1
m14*m13*m15*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c335 : 1
stoichiometry:c336 : 1
m108*0.1
nodelay
--
0
PMID: 17827709 Treatment of macrophages and dendritic cells (DCs) with dsRNA or LPS results in IRF3 activation, which leads to the expression of IFN-b and the IFN-inducible gene products.
p105
p111
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c337 : 1
stoichiometry:c338 : 1
stoichiometry:c339 : 1
stoichiometry:c340 : 1
stoichiometry:c341 : 1
stoichiometry:c342 : 1
m19305*m3902*m183*m1599*m97*0.1
nodelay
--
0
PMID: 17827709 This pathway requires a TIR domain-containing adaptor TICAM1/TRIF that interacts with TBK1, IKKi, RIP1, and TRAF6.
p107
p112
cso30:i:ME_Phosphorylation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c343 : 1
stoichiometry:c345 : 1
stoichiometry:c344 : 1
m977*m110*0.1
nodelay
--
0
PMID: 17827709 The nuclear translocation of IRF3 is triggered by phosphorylation with TBK1 and IKKi.
p46
p113
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c346 : 1
stoichiometry:c347 : 1
stoichiometry:c348 : 1
m46*m980*0.1
nodelay
--
0
PMID: 17827709,15361868 Formation of a signaling complex consisting of MyD88, IRAKs, and TRAF6 induces the phosphorylation of IRF7 by IRAK-1 and allows the nuclear translocation of this transcription factor
p67
p114
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c349 : 1
stoichiometry:c351 : 1
stoichiometry:c352 : 1
stoichiometry:c350 : 1
m80*m85*m6*0.1
nodelay
--
0
PMID: 17827709,11714830 In lung neutrophils, LPS-induced activation of NF-k B and the production of IL-1b and TNF-a are inhibited by PI3K inhibition. PMID: 17827709,12052830 In human monocytic THP1 cells, as well as in human peripheral blood monocytes, inhibitors of PI3K and a dominant negative Akt enhance the LPS-induced activation of AP-1, Egr-1, and NF-k B, which results in increased production of TNF-a
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c357 : 1
stoichiometry:c359 : 1
stoichiometry:c361 : 1
m13*m6*0.1
nodelay
--
0
PMID: 17827709,9794431 The activation of a receptor tyrosine kinase, RON, inhibits the LPS-induced expression of iNOS in murine peritoneal macrophages; this inhibition is recovered by wortmannin administration. PMID: 17827709,10868937 In b -pancreatic cells, LPS induces the expression of iNOS, which is abrogated by insulinlike growth factor-1 (IGF-1) PMID: 17827709 The effect of IGF-1 is inhibited by wortmannin, LY294002, and the overexpression of Dp85.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c353 : 1
stoichiometry:c39 : 1
m14*m5*m15*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c44 : 1
stoichiometry:c43 : 1
m14*m13*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
stoichiometry:c47 : 1
m5*m14*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
p15
p15
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c49 : 1
stoichiometry:c50 : 1
m72672*m2282*0.1
nodelay
--
0
PMID: 17827709 GSK-3 can differentially regulate the production of pro-inflammatory and anti-inflammatory cytokines by affecting the relative amounts of active transcription factors, CREB and the p65 subunit of NF-k B, that interact with a common coactivator CBP (CREB-binding protein).
p16
p16
cso30:i:ME_UnknownInactivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m72672*m1853*0.1
nodelay
--
0
PMID: 17827709,16007092 Since GSK-3 inactivates CREB, the inhibition of GSK- 3 augments the binding of CREB to CBP and competitively suppresses the binding of NF-k B p65 to the coactivator
p15
p17
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c54 : 1
stoichiometry:c55 : 1
stoichiometry:c56 : 1
m55295*m2282*0.1
nodelay
--
0
PMID: 17827709 GSK-3 can differentially regulate the production of pro-inflammatory and anti-inflammatory cytokines by affecting the relative amounts of active transcription factors, CREB and the p65 subunit of NF-k B, that interact with a common coactivator CBP (CREB-binding protein). PMID: 17827709,16007092 Since GSK-3 inactivates CREB, the inhibition of GSK- 3 augments the binding of CREB to CBP and competitively suppresses the binding of NF-k B p65 to the coactivator
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c58 : 1
stoichiometry:c59 : 1
m6*m1572*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c61 : 1
stoichiometry:c62 : 1
m6810*m6*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c6 : 1
stoichiometry:c5 : 1
m6*m5*0.1
nodelay
--
0
PMID: 17827709,9398628 Prior to the discovery of TLR, wortmannin was reported to enhance LPS-induced NO production in macrophages
p18
p20
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
p18
p21
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m19314*m18998*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m6*m19005*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
p18
p23
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m155701*m3964*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c77 : 1
m26*m1572*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c78 : 1
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m26*m6810*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
stoichiometry:c321 : 1
m25*m18998*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m19940*m1572*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c88 : 1
stoichiometry:c87 : 1
m1572*m31*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m23*m17258*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
p3
p3
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
1.0*0.1
nodelay
--
0
PMID: 17827709,10229863 The role of PI3K in this regulation was confirmed by the finding that a dominant negative mutant of PI3K (p110DN) increased, while a constitutively active form of PI3K (p110CAAT) suppressed the expression of inducible NO synthase (iNOS).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m28*m17258*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m32*m184*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m184*m34*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m35*m183*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m183*m33*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c108 : 1
stoichiometry:c107 : 1
stoichiometry:c112 : 1
m17258*m40*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c110 : 1
stoichiometry:c111 : 1
m19828*m100*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m39*m19940*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c116 : 1
stoichiometry:c117 : 1
m1572*m30*0.1
nodelay
--
0
PMID: 17827709,14698224,12539043,14519765,14556004 MyD88 is shared by all TLRs except TLR3, while TIRAP/Mal only binds to TLR2 and TLR4,TICAM- 1/TRIF binds exclusively to TLR3 and TLR4,and TICAM-2/TRAM binds only to TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c118 : 1
stoichiometry:c119 : 1
stoichiometry:c120 : 1
m42*m17258*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c9 : 1
m6*m5*0.1
nodelay
--
0
PMID: 17827709,12072439 The induction of cyclooxygenase by LPS is enhanced in the presence of wortmannin
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m43*m184*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m41*m184*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m44*m183*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c131 : 1
stoichiometry:c132 : 1
m45*m183*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
p44
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c135 : 1
m36*m1573*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
p44
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c136 : 1
stoichiometry:c137 : 1
stoichiometry:c138 : 1
m37*m1573*0.1
nodelay
--
0
PMID:17827709,9430229,12620219,10882101 MyD88 recruits IRAKs (IRAK1 and 4) to TLRs and allows IRAK1 to bind TRAF6, a key event leading to the activation of TAK1.
p46
p46
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c140 : 1
stoichiometry:c141 : 1
m47*m980*0.1
nodelay
--
0
PMID: 17827709,15361868 Formation of a signaling complex consisting of MyD88, IRAKs, and TRAF6 induces the phosphorylation of IRF7 by IRAK-1 and allows the nuclear translocation of this transcription factor
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m76*0.1
nodelay
--
0
PMID: 17827709,15361868 Formation of a signaling complex consisting of MyD88, IRAKs, and TRAF6 induces the phosphorylation of IRF7 by IRAK-1 and allows the nuclear translocation of this transcription factor
p48
p48
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c146 : 1
stoichiometry:c147 : 1
stoichiometry:c148 : 1
m1593*m181*m182*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 activates the IKK complex consisting of IKKa , IKKb , and NEMO/IKKg
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m38*m207*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 activates the IKK complex consisting of IKKa , IKKb , and NEMO/IKKg
p5
p5
cso30:i:ME_MetabolicReaction
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
stoichiometry:c14 : 1
m2000*m157492*0.1
nodelay
--
0
PMID: 17827709 SHIP is a lipid phosphatase that metabolizes PtdIns-3,4,5- P3 (PIP3) to produce PtdIns-3,4-P
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
stoichiometry:c154 : 1
m49*m48*0.1
nodelay
--
0
PMID: 17827709 The activated IKK complex phosphorylates Ik B leading to its ubiquitination
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
m63*0.1
nodelay
--
0
PMID: 17827709 The activated IKK complex phosphorylates Ik B leading to its ubiquitination
p52
p52
cso30:i:ME_UnknownDegradation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c157 : 1
stoichiometry:c158 : 1
stoichiometry:c159 : 1
m64*0.1
nodelay
--
0
PMID: 17827709 The resultant degradation of Ik B enables the bound NF-k B to translocate into the nucleus and to induce the expression of inflammatory cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m18*0.1
nodelay
--
0
PMID: 17827709 The resultant degradation of Ik B enables the bound NF-k B to translocate into the nucleus and to induce the expression of inflammatory cytokines.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m66*0.1
nodelay
--
0
PMID: 17827709 The resultant degradation of Ik B enables the bound NF-k B to translocate into the nucleus and to induce the expression of inflammatory cytokines.
p55
p55
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c165 : 1
stoichiometry:c166 : 1
m38*m3613*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 has the ability to act as a MAPK kinase kinase and is known to activate MAPK kinases, including MKK3/6, which in turn activate p38MAPK and SAPK/JNK.
p55
p56
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c167 : 1
stoichiometry:c168 : 1
stoichiometry:c169 : 1
m1875*m38*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 has the ability to act as a MAPK kinase kinase and is known to activate MAPK kinases, including MKK3/6, which in turn activate p38MAPK and SAPK/JNK.
p55
p57
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c171 : 1
stoichiometry:c172 : 1
m69*m70*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 has the ability to act as a MAPK kinase kinase and is known to activate MAPK kinases, including MKK3/6, which in turn activate p38MAPK and SAPK/JNK.
p55
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
stoichiometry:c175 : 1
m68*m70*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 has the ability to act as a MAPK kinase kinase and is known to activate MAPK kinases, including MKK3/6, which in turn activate p38MAPK and SAPK/JNK.
p55
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c177 : 1
stoichiometry:c178 : 1
m69*m72*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 has the ability to act as a MAPK kinase kinase and is known to activate MAPK kinases, including MKK3/6, which in turn activate p38MAPK and SAPK/JNK.
p6
p6
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c21 : 1
stoichiometry:c356 : 1
stoichiometry:c16 : 1
m6*0.1
nodelay
--
0
PMID: 17827709,9794431 The activation of a receptor tyrosine kinase, RON, inhibits the LPS-induced expression of iNOS in murine peritoneal macrophages; this inhibition is recovered by wortmannin administration. PMID: 17827709,10868937 In b -pancreatic cells, LPS induces the expression of iNOS, which is abrogated by insulinlike growth factor-1 (IGF-1) PMID: 17827709 The effect of IGF-1 is inhibited by wortmannin, LY294002, and the overexpression of Dp85.
p55
p60
cso30:i:ME_UnknownActivation
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c179 : 1
stoichiometry:c180 : 1
stoichiometry:c22 : 1
m68*m72*0.1
nodelay
--
0
PMID: 17827709,11460167 TAK1 has the ability to act as a MAPK kinase kinase and is known to activate MAPK kinases, including MKK3/6, which in turn activate p38MAPK and SAPK/JNK.
p61
p61
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c182 : 1
stoichiometry:c183 : 1
m74*m75*0.1
nodelay
--
0
PMID: 17827709,15372110 Another MAPK kinase kinase, Cot/Tpl2, which phosphorylates MEK1/2, is also activated downstream of TLR, although the mechanism is yet unknown.
p61
p62
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c184 : 1
stoichiometry:c185 : 1
stoichiometry:c186 : 1
m74*m1135*0.1
nodelay
--
0
PMID: 17827709,15372110 Another MAPK kinase kinase, Cot/Tpl2, which phosphorylates MEK1/2, is also activated downstream of TLR, although the mechanism is yet unknown.
p63
p63
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c187 : 1
stoichiometry:c188 : 1
m78*m1853*0.1
nodelay
--
0
PMID: 17827709,11035810,11884598 In addition to Akt, several other protein kinases, including cyclic AMP-dependent kinase and certain PKCs, are known to phosphorylate the inhibitory N-terminal site of GSK- 3.
p63
p64
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m79*m1853*0.1
nodelay
--
0
PMID: 17827709,11035810,11884598 In addition to Akt, several other protein kinases, including cyclic AMP-dependent kinase and certain PKCs, are known to phosphorylate the inhibitory N-terminal site of GSK- 3.
p63
p65
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c192 : 1
stoichiometry:c193 : 1
stoichiometry:c194 : 1
m92*m1853*0.1
nodelay
--
0
PMID: 17827709,11035810,11884598 In addition to Akt, several other protein kinases, including cyclic AMP-dependent kinase and certain PKCs, are known to phosphorylate the inhibitory N-terminal site of GSK- 3.
p66
p66
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c195 : 1
stoichiometry:c197 : 1
stoichiometry:c198 : 1
stoichiometry:c196 : 1
m93364*m6*m27*0.1
nodelay
--
0
PMID: 17827709,11714830 In lung neutrophils, LPS-induced activation of NF-k B and the production of IL-1b and TNF-a are inhibited by PI3K inhibition.
p67
p67
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c200 : 1
stoichiometry:c201 : 1
stoichiometry:c199 : 1
stoichiometry:c202 : 1
m6*m80*m87*0.1
nodelay
--
0
PMID: 17827709,11714830 In lung neutrophils, LPS-induced activation of NF-k B and the production of IL-1b and TNF-a are inhibited by PI3K inhibition. PMID: 17827709,12052830 In human monocytic THP1 cells, as well as in human peripheral blood monocytes, inhibitors of PI3K and a dominant negative Akt enhance the LPS-induced activation of AP-1, Egr-1, and NF-k B, which results in increased production of TNF-a
p66
p68
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c203 : 1
stoichiometry:c204 : 1
stoichiometry:c206 : 1
stoichiometry:c205 : 1
m27*m6*m81*0.1
nodelay
--
0
PMID: 17827709,11714830 In lung neutrophils, LPS-induced activation of NF-k B and the production of IL-1b and TNF-a are inhibited by PI3K inhibition.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c207 : 1
stoichiometry:c209 : 1
stoichiometry:c208 : 1
m14*m82*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a Was found to be increases in p85 knockout mice.
p7
p7
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c18 : 1
m93479*m6*m5*0.1
nodelay
--
0
PMID: 17827709,10066820 In C6 glial cells, LPS or wortmannin alone has no effect, but their combination induces iNOS production
p69
p70
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c210 : 1
stoichiometry:c211 : 1
stoichiometry:c212 : 1
m14*m93423*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a Was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c214 : 1
stoichiometry:c215 : 1
m14*m81*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a Was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c216 : 1
stoichiometry:c217 : 1
stoichiometry:c218 : 1
m26*m82*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
p69
p73
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c220 : 1
stoichiometry:c221 : 1
stoichiometry:c219 : 1
m26*m93423*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c223 : 1
stoichiometry:c224 : 1
stoichiometry:c222 : 1
m81*m26*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c225 : 1
stoichiometry:c226 : 1
stoichiometry:c227 : 1
m6*m82*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
p69
p76
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c242 : 1
stoichiometry:c243 : 1
m93423*m31*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
p69
p77
cso30:i:ME_Translation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c229 : 1
stoichiometry:c230 : 1
stoichiometry:c231 : 1
m93423*m6*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c233 : 1
stoichiometry:c234 : 1
stoichiometry:c232 : 1
m81*m6*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a Was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c235 : 1
stoichiometry:c236 : 1
stoichiometry:c237 : 1
m81*m31*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a Was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m6485*m3966*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c239 : 1
stoichiometry:c240 : 1
m82*m31*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c354 : 1
m93423*0.1
nodelay
--
0
PMID: 17827709,9261174 In addition, TLR2-, TLR4-, TLR5-, and TLR9-mediated production of IL-12, IFN-g , and TNF-a was found to be increases in Dcs obtained from p85 knockout mice.
p82
p82
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c244 : 1
stoichiometry:c246 : 1
stoichiometry:c251 : 1
stoichiometry:c245 : 1
m219*m6*m85*0.1
nodelay
--
0
PMID: 17827709,12052830 In human monocytic THP1 cells, as well as in human peripheral blood monocytes, inhibitors of PI3K and a dominant negative Akt enhance the LPS-induced activation of AP-1, Egr-1, and NF-k B, which results in increased production of TNF-a
p82
p83
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c247 : 1
stoichiometry:c248 : 1
stoichiometry:c250 : 1
stoichiometry:c249 : 1
m6*m2058*m85*0.1
nodelay
--
0
PMID: 17827709,12052830 In human monocytic THP1 cells, as well as in human peripheral blood monocytes, inhibitors of PI3K and a dominant negative Akt enhance the LPS-induced activation of AP-1, Egr-1, and NF-k B, which results in increased production of TNF-a
p84
p84
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c252 : 1
stoichiometry:c253 : 1
stoichiometry:c254 : 1
m26*m27*0.1
nodelay
--
0
PMID: 17827709 It was shown that most TLRs, including at least TLR2, TLR3, TLR4, TLR5, and TLR9, activate PI3K.
p84
p85
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c255 : 1
stoichiometry:c256 : 1
stoichiometry:c284 : 1
stoichiometry:c257 : 1
m6*m27*m184*0.1
nodelay
--
0
PMID: 17827709 It was shown that most TLRs, including at least TLR2, TLR3, TLR4, TLR5, and TLR9, activate PI3K. PMID: 17827709,12516562 It is reported that IL-1b -, IL-18-, and LPS-induced activation of PI3K is diminished in IRAK-1 deficient cells.
p84
p86
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c258 : 1
stoichiometry:c259 : 1
stoichiometry:c260 : 1
m31*m27*0.1
nodelay
--
0
PMID: 17827709 It was shown that most TLRs, including at least TLR2, TLR3, TLR4, TLR5, and TLR9, activate PI3K.
p84
p87
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c261 : 1
stoichiometry:c262 : 1
stoichiometry:c263 : 1
m19314*m27*0.1
nodelay
--
0
PMID: 17827709 It was shown that most TLRs, including at least TLR2, TLR3, TLR4, TLR5, and TLR9, activate PI3K.
p84
p88
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c264 : 1
stoichiometry:c265 : 1
stoichiometry:c266 : 1
m14*m27*0.1
nodelay
--
0
PMID: 17827709 It was shown that most TLRs, including at least TLR2, TLR3, TLR4, TLR5, and TLR9, activate PI3K.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c267 : 1
stoichiometry:c268 : 1
stoichiometry:c269 : 1
m86*m23*0.1
nodelay
--
0
PMID: 17827709,16644730 In fact, MyD88 associates with p85 in response to flagellin and LPS
p9
p9
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c28 : 1
m93248*m14*m13*0.1
nodelay
--
0
PMID: 17827709,16670329 In epithelial cells, flagellin-induced (TLR5-mediated) production of NO, IL-6, and IL-8 was increased in the presence of wortmannin or LY294002
p89
p90
cso30:i:ME_Binding
cso30:i:CC_EndosomeMembrane
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c270 : 1
stoichiometry:c271 : 1
stoichiometry:c272 : 1
m14*m1572*0.1
nodelay
--
0
PMID: 17827709,16644730 In fact, MyD88 associates with p85 in response to flagellin and LPS
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c273 : 1
stoichiometry:c274 : 1
stoichiometry:c275 : 1
m86*m89*0.1
nodelay
--
0
PMID: 17827709,16644730 In fact, MyD88 associates with p85 in response to flagellin and LPS
p92
p92
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c276 : 1
stoichiometry:c277 : 1
stoichiometry:c279 : 1
stoichiometry:c278 : 1
m1611*m27*m184*0.1
nodelay
--
0
PMID: 17827709,12516562 It is reported that IL-1b -, IL-18-, and LPS-induced activation of PI3K is diminished in IRAK-1 deficient cells.
p92
p93
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c280 : 1
stoichiometry:c281 : 1
stoichiometry:c282 : 1
stoichiometry:c283 : 1
m1591*m184*m27*0.1
nodelay
--
0
PMID: 17827709,12516562 It is reported that IL-1b -, IL-18-, and LPS-induced activation of PI3K is diminished in IRAK-1 deficient cells.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c285 : 1
stoichiometry:c286 : 1
stoichiometry:c287 : 1
m91*m86*0.1
nodelay
--
0
--
p95
p95
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c288 : 1
stoichiometry:c289 : 1
stoichiometry:c290 : 1
m93*m27*0.1
nodelay
--
0
PMID: 17827709 Several reports indicate that p85 binds the receptor itself to activate PI3K.
p96
p96
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c291 : 1
stoichiometry:c292 : 1
stoichiometry:c293 : 1
m26*m86*0.1
nodelay
--
0
PMID: 17827709,11101877 For example, TLR2 is tyrosine-phosphorylated within the YXXM motif of its TIR domain and directly binds p85.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c294 : 1
stoichiometry:c295 : 1
stoichiometry:c296 : 1
m86*m19305*0.1
nodelay
--
0
PMID: 17827709 Upon TLR3 stimulation, another adaptor, TICAM1/TRIF, may act in the recruitment of p85.
p98
p98
cso30:i:ME_Binding
cso30:i:CC_Cytoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c297 : 1
stoichiometry:c298 : 1
stoichiometry:c299 : 1
m2113*m18998*0.1
nodelay
--
0
PMID: 17827709,10868937 The association of the catalytically active form of p110a (p110aCAAT) with TRIF has been reported when both are transfected into 293T cells
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c300 : 1
stoichiometry:c301 : 1
stoichiometry:c302 : 1
m97*m86*0.1
nodelay
--
0
PMID: 17827709,15280422 RIP1 is another candidate for the adaptor of p85 in TLR signaling, since neither LPS nor CpG activates Akt in cells lacking RIP1.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--